Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

12.21
-0.3100-2.48%
Post-market: 12.11-0.1000-0.82%19:26 EDT
Volume:2.07M
Turnover:25.45M
Market Cap:2.12B
PE:-9.54
High:12.71
Open:12.59
Low:12.07
Close:12.52
52wk High:12.91
52wk Low:5.79
Shares:174.00M
Float Shares:137.00M
Volume Ratio:1.33
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2802
EPS(LYR):-1.2227
ROE:-63.41%
ROA:-31.14%
PB:6.94
PE(LYR):-9.99

Loading ...

Strategic Advancements and Financial Updates Drive Buy Rating for Ocular Therapeutix

TIPRANKS
·
May 06

Ocular Therapeutix Stock Falls as 1Q Misses Targets, R&D Expenses Double

Dow Jones
·
May 05

Ocular Therapeutix Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Ocular Therapeutix Q1 Net Loss Narrows, Revenue Falls

MT Newswires Live
·
May 05

Ocular Therapeutix reports Q1 EPS (38c), consensus (28c)

TIPRANKS
·
May 05

Ocular Therapeutix sees cash runway into 2028

TIPRANKS
·
May 05

Earnings Flash (OCUL) Ocular Therapeutix Posts Q1 Net Loss $0.38 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
May 05

Ocular Therapeutix Q1 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.70M Miss $16.83M Estimate

Benzinga
·
May 05

BRIEF-Ocular Therapeutix Q1 EPS USD -0.38 Vs. IBES Estimate USD -0.29

Reuters
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 05

Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for

Zacks
·
Apr 29

Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences

GlobeNewswire
·
Apr 29

Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025

GlobeNewswire
·
Apr 28

Piper Sandler Keeps Their Buy Rating on Ocular Therapeutix (OCUL)

TIPRANKS
·
Apr 21

Investors bid Ocular Therapeutix (NASDAQ:OCUL) up US$202m despite increasing losses YoY, taking three-year CAGR to 24%

Simply Wall St.
·
Apr 15

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 12

Ocular Therapeutix Initiated at Outperform by William Blair

Dow Jones
·
Apr 08

William Blair Initiates Ocular Therapeutix With Outperform Rating

MT Newswires Live
·
Apr 08

Ocular Therapeutix initiated with an Outperform at William Blair

TIPRANKS
·
Apr 08

Top Premarket Decliners

MT Newswires Live
·
Apr 02